SOX2 and neoplasm: Inhibition of UPF1 may be used to lower the chances of CSCs being the tumor origin and may be beneficial for chemoprevention while sparing normal endometrial stem cells via the LINC00963/miR-508-5p/SOX2 pathway (Fig. 8J).